XML 62 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
6 Months Ended
Jun. 30, 2014
Stock-Based Compensation [Abstract]  
Stock-Based Compensation

 

 

NOTE 6 - STOCK-BASED COMPENSATION

The Company has stock-based incentive arrangements to attract and retain key personnel. In May 2005, the 2005 Equity Compensation Plan (the “Plan”) was approved by shareholders, which authorizes the issuance of restricted stock, stock appreciation rights, stock units and stock options to the Board of Directors and key employees. Compensation expense for service-based awards is recognized over the vesting period. Performance-based awards are recognized based on a vesting schedule, if applicable, and the probability of achieving goals specified at the time of the grant.

 

Stock-based compensation expense totaled $146,000 and $147,000 for the six months ended June 30, 2014 and 2013, respectively, which consisted of the vesting of grants of restricted stock and  restricted stock units. Stock-based compensation for the six months ended June 30, 2013 included director compensation of $3,000 for stock granted in lieu of cash compensation. All outstanding options were fully vested and the Company has not granted any stock options since 2007.

 

The fair value of the Company’s outstanding employee stock options is estimated on the date of grant using the Black-Scholes option pricing model. The Company estimates expected market price volatility and expected term of the options based on historical data and other factors.

 

The exercise price for options granted is set at the discretion of the committee administering the Plan, but is not less than the market value of the shares as of the date of grant. An option’s maximum term is 10 years and the options vest at the discretion of the committee.  

 

The following tables below summarize outstanding and exercisable options at June 30, 2014 and December 31, 2013.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

Weighted-Average

 

 

 

 

Average

 

Aggregate

 

Contractual Life

 

 

 

 

Exercise

 

Intrinsic

 

Remaining In

(dollars in thousands, except per

  share amounts)

 

Shares

 

Price

 

Value

 

Years

 

 

 

 

 

 

 

 

 

Outstanding at January 1, 2014

 

159,517 

 

$                    20.12 

 

$                      347 

 

 

Exercised

 

(6,665)

 

15.89 

 

34 

 

 

Outstanding at June 30, 2014

 

152,852 

 

$                    20.30 

 

$                      611 

 

0.7 

 

 

 

 

 

 

 

 

 

Exercisable at June 30, 2014

 

152,852 

 

$                    20.30 

 

$                      611 

 

0.7 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

Weighted-Average

 

 

 

 

Average

 

Aggregate

 

Contractual Life

 

 

 

 

Exercise

 

Intrinsic

 

Remaining In

(dollars in thousands, except per

  share amounts)

 

Shares

 

Price

 

Value

 

Years

 

 

 

 

 

 

 

 

 

Outstanding at January 1, 2013

 

236,059 

 

$                    18.49 

 

$                      164 

 

 

Exercised

 

(55,672)

 

13.16 

 

310 

 

 

Forfeited

 

(20,870)

 

20.27 

 

 

 

 

Outstanding at December 31, 2013

 

159,517 

 

$                    20.12 

 

$                      347 

 

1.0 

 

 

 

 

 

 

 

 

 

Exercisable at December 31, 2013

 

159,517 

 

$                    20.12 

 

$                      347 

 

1.0 

 

Options outstanding are all currently exercisable and are summarized as follows: 

 

 

 

 

 

 

 

Shares Outstanding

 

Weighted Average

 

Weighted Average

June 30, 2014

 

Remaining Contractual Life

 

Exercise Price

65,417

 

1 years

 

$

15.89

66,224

 

2 years

 

 

22.29

21,211

 

4 years

 

 

27.70

152,852

 

 

 

$

20.30

  

The aggregate intrinsic value of outstanding stock options and exercisable stock options was $611,000 and $347,000 at June 30, 2014 and December 31, 2013, respectively. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the period, which was $23.75 and $20.71 per share at June 30, 2014 and December 31, 2013, respectively, and the exercise price multiplied by the number of in the money options outstanding.

 

The Company has outstanding restricted stock and stock units granted in accordance with the Plan. The vesting period for granted restricted stock is between three and five years. As of June 30, 2014, unrecognized stock compensation expense was $573,000.  The following tables summarize the unvested restricted stock awards and units outstanding at June 30, 2014 and December 31, 2013, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

Restricted Stock

 

Restricted Stock Units

 

 

 

 

 

 

 

 

 

 

 

Number of Shares

 

Weighted
 Average Grant
Date Fair Value

 

Number of Units

 

Fair Value

 

 

 

 

 

 

 

 

 

Nonvested at January 1, 2014

 

16,832 

 

$                    17.86 

 

4,210 

 

$                    20.71 

Granted

 

33,460 

 

21.35 

 

 -

 

 -

Vested

 

(17,105)

 

15.39 

 

(2,105)

 

20.29 

 

 

 

 

 

 

 

 

 

Nonvested at June 30, 2014

 

33,187 

 

$                    20.90 

 

2,105 

 

$                    23.75 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted Stock

 

Restricted Stock Units

 

 

Number of Shares

 

Weighted
 Average Grant
Date Fair Value

 

Number of Units

 

Fair Value

 

 

 

 

 

 

 

 

 

Nonvested at January 1, 2013

 

23,569 

 

$                    15.64 

 

5,211 

 

$                    15.98 

Granted

 

13,656 

 

18.00 

 

2,105 

 

20.71 

Vested

 

(20,393)

 

18.79 

 

(3,106)

 

15.98 

 

 

 

 

 

 

 

 

 

Nonvested at December 31, 2013

 

16,832 

 

$                    17.86 

 

4,210 

 

$                    20.71